Craft

Tandem Diabetes Care

Stock Price

$26.3

2023-08-28

Market Capitalization

$1.7 B

2023-08-28

Revenue

$801.2 M

FY, 2022

Tandem Diabetes Care Summary

Company Summary

Overview
Tandem Diabetes Care is a medical device company that engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is primarily focused on manufacturing, sales, and support of its flagship pump platform t:slim X2. In addition, it sells disposable products including insulin cartridges, infusion sets, belt clips, and cases for use with pumps. Tandem Diabetes Care also offers t:connect, a data management application to display diabetes therapy management data, integrated CGMs, and supported blood glucose meters.
Type
Public
Status
Active
Founded
2006
HQ
San Diego, CA, US | view all locations
Website
https://www.tandemdiabetes.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • John Sheridan

    John Sheridan, President and Chief Executive Officer, Director

  • Leigh Vosseller

    Leigh Vosseller, Executive Vice President, Chief Financial Officer and Treasurer

  • David Berger

    David Berger, Executive Vice President and Chief Operating Officer

  • Brian Hansen

    Brian Hansen, Executive Vice President and Chief Commercial Officer

Operating MetricsView all

Facilities Leased (US), square feet

417K
13.6%

FY, 2022

Pumps Shipped to Date

420K
27.3%

FY, 2022

Products

3

FY, 2022

LocationsView all

3 locations detected

  • San Diego, CA HQ

    United States

    11075 Roselle St

  • Boise, ID

    United States

    1500 Shoreline Dr

  • San Diego, CA

    United States

    10937 Vista Sorrento Pkwy

Tandem Diabetes Care Financials

Summary Financials

Revenue (Q2, 2023)
$195.9M
Gross profit (Q2, 2023)
$101.7M
Net income (Q2, 2023)
($35.8M)
Cash (Q2, 2023)
$130.8M
EBIT (Q2, 2023)
($38.8M)
Enterprise value
$1.9B

Footer menu